Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurohumoral Effects of Candesartan, Atenolol, and HCTZ in Hypertension
NCT00232882Phase 4Completed
- Sponsor
- Montreal Clinical Research Institute
- Start
- Dec 2003
- Primary completion
- Apr 2006
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of candesartan cilexetil in essential hypertension, sponsored by Montreal Clinical Research Institute. Started Dec 2003; status: completed.
02
Drugs
candesartan cilexetil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00232882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00232882.